240
Views
4
CrossRef citations to date
0
Altmetric
Osteoporosis Menopausal Risk

Osteoporosis's Menopausal Epidemiological Risk Observation (O.M.E.R.O.) study

, , &
Pages 992-998 | Received 17 May 2015, Accepted 14 Jun 2015, Published online: 14 Jul 2015

References

  • NIH consensus development panel on osteoporosis prevention, diagnosis, and therapy, JAMA 2001;285:785–95
  • Seeman E. Bone quality. Adv Osteoporos Fract Manag 2002;2:2–8
  • Reginster JY, Burlet N. Osteoporosis: a still increasing prevalence. Bone 2006;38:S4–9
  • Ström O, Borgström F, Kanis JA, et al. Osteoporosis: burden, health care provision and opportunities in the EU: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 2011;6:59–155
  • Tosteson AN, Grove MR, Hammond CS, et al. Early discontinuation of treatment for osteoporosis. Am J Med 2003;115:209–16
  • Caro JJ, Ishak KJ, Huybrechts KF, et al. The impact of compliance with osteoporosis therapy on fracture rates in actual practice. Osteoporos Int 2004;15:1003–8
  • Siris ES, Chen YT, Abbott TA, et al. Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med 2004;164:1108–12
  • Kanis JA, Oden A, Johnell O, et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 2007;18:1033–46
  • Kanis JA, Hans D, Cooper C, et al. Interpretation and use of FRAX in clinical practice. Osteoporos Int 2011;22:2395–411
  • National Osteoporosis Foundation. Clinician's guide to prevention and treatment of osteoporosis. Washington (DC): National Osteoporosis Foundation; 2014
  • World Health Organization. Assessment of osteoporosis at the primary health care level. Geneva: WHO; 2007. Available from: www.who.int/chp/topics/rheumatic/en/index.html [last accessed 13 Feb 2015]
  • Kanis JA, on behalf of the World Health Organization Scientific Group. Assessment of osteoporosis at the primary healthcare level. Technical report. WHO Collaborating Centre, University of Sheffield, UK; 2008. Available from: http://www.shef.ac.uk/FRAX/index.htm; FRAX® http://www.shef.ac.uk/FRAX [last accessed 13 Feb 2015]
  • Kanis JA, Oden A, Johansson H, et al. FRAX® and its applications to clinical practice. Bone 2009;44:734–43
  • Kanis JA, Johnell O, De Laet C, et al. A meta-analysis of previous fracture and subsequent fracture risk. Bone 2004;35:375–82
  • Klotzbuecher CM, Ross PD, Landsman PB, et al. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 2000;15:721–39
  • Lindsay R, Silverman SL, Cooper C, et al. Risk of new vertebral fracture in the year following a fracture. JAMA 2001;285:320–3
  • Gehlbach S, Saag KG, Adachi JD, et al. Previous fractures at multiple sites increase the risk for subsequent fractures: the global longitudinal study of osteoporosis in women. J Bone Miner Res 2012;27:645–53
  • Hauser B, Riches PL, Wilson JF, et al. Prevalence and clinical prediction of osteoporosis in a contemporary cohort of patients with rheumatoid arthritis. Rheumatology (Oxford) 2014;53:1759–66
  • Waugh EJ, Lam MA, Hawker GA, et al. Risk factors for low bone mass in healthy 40–60 year old women: a systematic review of the literature. Osteoporos Int 2009;20:1–21
  • Kanis JA, Johnell O, Oden A, et al. Smoking and fracture risk: a meta-analysis. Osteoporos Int 2005;16:155–62
  • Krall EA, Dawson-Hughes B. Smoking increases bone loss and decreases intestinal calcium absorption. J Bone Miner Res 1999;14:215–20
  • Kanis JA, Johansson H, Oden A, et al. A meta-analysis of milk intake and fracture risk: low-utility for case finding. Osteoporos Int 2005;16:799–804
  • Bonjour JP, Brandolini-Bunlon M, Boirie Y, et al. Inhibition of bone turnover by milk intake in postmenopausal women. Br J Nutr 2008;100:866–74
  • Sahni S, Mangano KM, Tucker KL, et al. Protective association of milk intake on the risk of hip fracture: results from the Framingham Original Cohort. J Bone Miner Res 2014;29:1756–62
  • Rizzoli R. Dairy products, yogurts, and bone health. Am J Clin Nutr 2014;99:1256S–62S
  • van Staa TP, Leufkens HG, Abenhaim L, et al. Use of oral corticosteroids and risk of fractures. J Bone Miner Res 2000;15:993–1000
  • Kanis JA, Johansson H, Oden A, et al. A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 2004;19:893–9
  • Black DM, Arden NK, Palermo L, et al. Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group. J Bone Miner Res 1999;14:821–8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.